Subcutaneous Interferon-β1a Does Not Increase the Risk of Stroke in Patients with Multiple Sclerosis: Analysis of Pooled Clinical Trials and Post-Marketing Surveillance

INTRODUCTION: Previous studies suggest that multiple sclerosis (MS) patients have a greater stroke risk than the general population but there is limited evidence of stroke risk in patients receiving disease-modifying treatment. We assessed stroke risk in MS patients treated with subcutaneous interfe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabidó, Meritxell, Venkatesh, Saritha, Hayward, Brooke, Aldridge, Julie, Gillett, Alan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224000/
https://www.ncbi.nlm.nih.gov/pubmed/30255416
http://dx.doi.org/10.1007/s12325-018-0790-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6224000/
https://www.ncbi.nlm.nih.gov/pubmed/30255416
http://dx.doi.org/10.1007/s12325-018-0790-1

Ejemplares similares